|
1
|
Negi S and Anand A: Atherosclerotic
coronary heart disease-epidemiology, classification and management.
Cardiovasc Hematol Disord Drug Targets. 10:257–261. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moran A, Gu D, Zhao D, et al: Future
cardiovascular disease in China: Markov model and risk factor
scenario projections from the coronary heart disease policy model -
China. Circ Cardiovasc Qual and Outcomes. 3:243–252. 2010.
View Article : Google Scholar
|
|
3
|
Xu MQ, Ye Z, Hu FB and He L: Quantitative
assessment of the effect of angiotensinogen gene polymorphisms on
the risk of coronary heart disease. Circulation. 116:1356–1366.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zafarmand MH, van der Schouw YT, Grobbee
DE, et al: The M235T polymorphism in the AGT gene and CHD risk:
evidence of a Hardy-Weinberg equilibrium violation and publication
bias in a meta-analysis. PLoS One. 3:e25332008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen D, Liu JL, Liu Y, et al: Lack of an
association between -308G>A polymorphism of the TNF-α gene and
liver cirrhosis risk based on a meta-analysis. Genet Mol Res.
10:2765–2774. 2011.
|
|
6
|
Mantel N and Haenszel W: Statistical
aspects of the analysis of data from retrospective studies of
disease. J Natl Cancer Inst. 22:719–748. 1959.PubMed/NCBI
|
|
7
|
DerSimonian R and Laird N: Meta-analysis
in clinical trials. Control Clin Trials. 7:177–188. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ko YL, Ko YS, Wang SM, et al:
Angiotensinogen and angiotensin-I converting enzyme gene
polymorphisms and the risk of coronary artery disease in Chinese.
Hum Genet. 100:210–214. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen D, Zhang M, Fan W, et al: A molecular
variant of angiotensinogen gene is associated with myocardial
infarction in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
15:133–135. 1998.(In Chinese).
|
|
11
|
Sheu WH, Lee WJ, Jeng CY, et al:
Angiotensinogen gene polymorphism is associated with insulin
resistance in nondiabetic men with or without coronary heart
disease. Am Heart J. 136:125–131. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xie Y, Zhang FM, Ma WZ, et al: Association
between gene polymorphism of renin-angiotensin system and coronary
heart disease. Nanjing Yi Ke Da Xue Xue Bao. 21:488–491. 2001.(In
Chinese).
|
|
13
|
Zhu TB, Xu W, Yang ZJ, et al: Association
analysis of three polymorphism of renin-angiotensin system genes
with coronary heart disease. Jiangsu Med J. 28:745–746. 2002.(In
Chinese).
|
|
14
|
Gu WD, Zhu JH, Pan M, et al: Effects of
angiotensinogen and apolipoprotein E gene polymorphisms on coronary
heart disease. Nan Tong Yi Xue Yuan Xue Bao. 23:394–395. 2003.(In
Chinese).
|
|
15
|
Zhu TN, Pan JQ, Shen ZJ, et al: Gene
polymorphisms of renin-angiotensin system and coronary thrombosis
disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 12:674–679. 2004.(In
Chinese).
|
|
16
|
Li L, Fan XH, Zhang YW, et al: Association
between angiotensinogen gene polymorphism and severity of coronary
artery stenosis. J Med Forum. 25:12–14. 2004.(In Chinese).
|
|
17
|
Ren J, Jia YP, Lv JY and Guo XH:
Relationship between angiotensinogen gene M235T polymorphism and
coronary heart disease. J Shanxi Med Univ. 36:439–442. 2005.(In
Chinese).
|
|
18
|
Zhang XH, Lu ZL and Liu L: Coronary heart
disease in China. Heart. 94:1126–1131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Critchley J, Liu J, Zhao D, et al:
Explaining the increase in coronary heart disease mortality in
Beijing between 1984 and 1999. Circulation. 110:1236–1244. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jeunemaitre X, Soubrier F, Kotelevtsev YV,
et al: Molecular basis of human hypertension: role of
angiotensinogen. Cell. 71:169–180. 1992. View Article : Google Scholar
|
|
21
|
Henrion D, Kubis N and Lévy BI:
Physiological and pathophysiological functions of the AT(2) subtype
receptor of angiotensin II: from large arteries to the
microcirculation. Hypertension. 38:1150–1157. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Horiuchi M, Akishita M and Dzau VJ: Recent
progress in angiotensin II type 2 receptor research in the
cardiovascular system. Hypertension. 33:613–21. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dietz R, von Harsdorf R, Gross M, et al:
Angiotensin II and coronary artery disease, congestive heart
failure, and sudden cardiac death. Basic Res Cardiol. 93:101–108.
1998. View Article : Google Scholar : PubMed/NCBI
|
